{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:36:55Z","timestamp":1761709015801},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T00:00:00Z","timestamp":1407888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12918-014-0098-y","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T03:05:06Z","timestamp":1407812706000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy"],"prefix":"10.1186","volume":"8","author":[{"given":"Dan","family":"Tian","sequence":"first","affiliation":[]},{"given":"Pamela K","family":"Kreeger","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,8,13]]},"reference":[{"key":"98_CR1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199702273360907","volume":"336","author":"D Le Roith","year":"1997","unstructured":"Le Roith D: Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med. 1997, 336: 633-640.","journal-title":"N Engl J Med"},{"key":"98_CR2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ecl.2012.04.014","volume":"41","author":"SJ Weroha","year":"2012","unstructured":"Weroha SJ, Haluska P: The insulin-like growth factor system in cancer. Endocrinol Metab Clin North Am. 2012, 41: 335-350. vi","journal-title":"Endocrinol Metab Clin North Am"},{"key":"98_CR3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11487","volume":"107","author":"R Baserga","year":"2003","unstructured":"Baserga R, Peruzzi F, Reiss K: The IGF-1 receptor in cancer biology. Int J Cancer. 2003, 107: 873-877.","journal-title":"Int J Cancer"},{"key":"98_CR4","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1128\/MCB.14.6.3604","volume":"14","author":"C Sell","year":"1994","unstructured":"Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R: Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol. 1994, 14: 3604-3612.","journal-title":"Mol Cell Biol"},{"key":"98_CR5","first-page":"2463","volume":"55","author":"M Resnicoff","year":"1995","unstructured":"Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R: The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 1995, 55: 2463-2469.","journal-title":"Cancer Res"},{"key":"98_CR6","doi-asserted-by":"crossref","first-page":"e48071","DOI":"10.1371\/journal.pone.0048071","volume":"7","author":"R Epaud","year":"2012","unstructured":"Epaud R, Aubey F, Xu J, Chaker Z, Clemessy M, Dautin A, Ahamed K, Bonora M, Hoyeau N, Flejou JF, Mailleux A, Clement A, Henrion-Caude A, Holzenberger M: Knockout of insulin-like growth factor-1 receptor impairs distal lung morphogenesis. PLoS One. 2012, 7: e48071-","journal-title":"PLoS One"},{"key":"98_CR7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1749-6632.1993.tb26240.x","volume":"692","author":"L Powell-Braxton","year":"1993","unstructured":"Powell-Braxton L, Hollingshead P, Giltinan D, Pitts-Meek S, Stewart T: Inactivation of the IGF-I gene in mice results in perinatal lethality. Ann N Y Acad Sci. 1993, 692: 300-301.","journal-title":"Ann N Y Acad Sci"},{"key":"98_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(05)80085-6","volume":"75","author":"J Baker","year":"1993","unstructured":"Baker J, Liu JP, Robertson EJ, Efstratiadis A: Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993, 75: 73-82.","journal-title":"Cell"},{"key":"98_CR9","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1210\/endo.140.11.7095","volume":"140","author":"W Ruan","year":"1999","unstructured":"Ruan W, Kleinberg DL: Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology. 1999, 140: 5075-5081.","journal-title":"Endocrinology"},{"key":"98_CR10","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/endo.140.5.6721","volume":"140","author":"W Ruan","year":"1999","unstructured":"Ruan W, Powell-Braxton L, Kopchick JJ, Kleinberg DL: Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology. 1999, 140: 1984-1989.","journal-title":"Endocrinology"},{"key":"98_CR11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<293::AID-DVG12>3.0.CO;2-S","volume":"24","author":"SA Rogers","year":"1999","unstructured":"Rogers SA, Powell-Braxton L, Hammerman MR: Insulin-like growth factor I regulates renal development in rodents. Dev Genet. 1999, 24: 293-298.","journal-title":"Dev Genet"},{"key":"98_CR12","first-page":"59","volume":"75","author":"JP Liu","year":"1993","unstructured":"Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993, 75: 59-72.","journal-title":"Cell"},{"key":"98_CR13","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1101\/gad.7.12b.2609","volume":"7","author":"L Powell-Braxton","year":"1993","unstructured":"Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA: IGF-I is required for normal embryonic growth in mice. Genes Dev. 1993, 7: 2609-2617.","journal-title":"Genes Dev"},{"key":"98_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ghir.2004.02.004","volume":"14","author":"C Bahr","year":"2004","unstructured":"Bahr C, Groner B: The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy. Growth Horm IGF Res. 2004, 14: 287-295.","journal-title":"Growth Horm IGF Res"},{"key":"98_CR15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/13543784.13.12.1569","volume":"13","author":"H Zhang","year":"2004","unstructured":"Zhang H, Yee D: The therapeutic potential of agents targeting the type I insulin-like growth factor receptor. Expert Opin Investig Drugs. 2004, 13: 1569-1577.","journal-title":"Expert Opin Investig Drugs"},{"key":"98_CR16","first-page":"3","volume":"16","author":"JI Jones","year":"1995","unstructured":"Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995, 16: 3-34.","journal-title":"Endocr Rev"},{"key":"98_CR17","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","volume":"92","author":"H Yu","year":"2000","unstructured":"Yu H, Rohan T: Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000, 92: 1472-1489.","journal-title":"J Natl Cancer Inst"},{"key":"98_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0305-0491(98)10106-2","volume":"121","author":"AA Butler","year":"1998","unstructured":"Butler AA, Yakar S, Gewolb IH, Karas M, Okubo Y, LeRoith D: Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp Biochem Physiol B Biochem Mol Biol. 1998, 121: 19-26.","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"98_CR19","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1158\/1078-0432.CCR-08-2530","volume":"15","author":"P Sabbatini","year":"2009","unstructured":"Sabbatini P, Rowand JL, Groy A, Korenchuk S, Liu Q, Atkins C, Dumble M, Yang J, Anderson K, Wilson BJ, Emmitte KA, Rabindran SK, Kumar R: Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase. Clin Cancer Res. 2009, 15: 3058-3067.","journal-title":"Clin Cancer Res"},{"key":"98_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/0470869976.ch8","volume":"262","author":"M Foti","year":"2004","unstructured":"Foti M, Moukil MA, Dudognon P, Carpentier JL: Insulin and IGF-1 receptor trafficking and signalling. Novartis Found Symp. 2004, 262: 125-141. discussion 141\u2013127, 265\u2013128","journal-title":"Novartis Found Symp"},{"key":"98_CR21","doi-asserted-by":"crossref","first-page":"22513","DOI":"10.1074\/jbc.M704309200","volume":"282","author":"RJ Romanelli","year":"2007","unstructured":"Romanelli RJ, LeBeau AP, Fulmer CG, Lazzarino DA, Hochberg A, Wood TL: Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt. J Biol Chem. 2007, 282: 22513-22524.","journal-title":"J Biol Chem"},{"key":"98_CR22","doi-asserted-by":"crossref","first-page":"31640","DOI":"10.1074\/jbc.273.48.31640","volume":"273","author":"FT Lin","year":"1998","unstructured":"Lin FT, Daaka Y, Lefkowitz RJ: beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J Biol Chem. 1998, 273: 31640-31643.","journal-title":"J Biol Chem"},{"key":"98_CR23","first-page":"4314","volume":"59","author":"GR Devi","year":"1999","unstructured":"Devi GR, De Souza AT, Byrd JC, Jirtle RL, MacDonald RG: Altered ligand binding by insulin-like growth factor II\/mannose 6-phosphate receptors bearing missense mutations in human cancers. Cancer Res. 1999, 59: 4314-4319.","journal-title":"Cancer Res"},{"key":"98_CR24","first-page":"761","volume":"20","author":"V Hwa","year":"1999","unstructured":"Hwa V, Oh Y, Rosenfeld RG: The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999, 20: 761-787.","journal-title":"Endocr Rev"},{"key":"98_CR25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(03)00159-9","volume":"195","author":"D LeRoith","year":"2003","unstructured":"LeRoith D, Roberts CT: The insulin-like growth factor system and cancer. Cancer Lett. 2003, 195: 127-137.","journal-title":"Cancer Lett"},{"key":"98_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20060086","volume":"395","author":"J Beattie","year":"2006","unstructured":"Beattie J, Allan GJ, Lochrie JD, Flint DJ: Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J. 2006, 395: 1-19.","journal-title":"Biochem J"},{"key":"98_CR27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","volume":"23","author":"SM Firth","year":"2002","unstructured":"Firth SM, Baxter RC: Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002, 23: 824-854.","journal-title":"Endocr Rev"},{"key":"98_CR28","doi-asserted-by":"crossref","first-page":"29676","DOI":"10.1074\/jbc.M301965200","volume":"278","author":"AJ Butt","year":"2003","unstructured":"Butt AJ, Dickson KA, McDougall F, Baxter RC: Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem. 2003, 278: 29676-29685.","journal-title":"J Biol Chem"},{"key":"98_CR29","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1210\/endo.141.6.7520","volume":"141","author":"H Miyake","year":"2000","unstructured":"Miyake H, Nelson C, Rennie PS, Gleave ME: Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3\u2032-kinase pathway. Endocrinology. 2000, 141: 2257-2265.","journal-title":"Endocrinology"},{"key":"98_CR30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2353\/ajpath.2010.090512","volume":"177","author":"XL Xu","year":"2010","unstructured":"Xu XL, Lee TC, Offor N, Cheng C, Liu A, Fang Y, Jhanwar SC, Abramson DH, Cobrinik D: Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5. Am J Pathol. 2010, 177: 424-435.","journal-title":"Am J Pathol"},{"key":"98_CR31","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1073\/pnas.88.17.7481","volume":"88","author":"JI Jones","year":"1991","unstructured":"Jones JI, D\u2019Ercole AJ, Camacho-Hubner C, Clemmons DR: Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci U S A. 1991, 88: 7481-7485.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"98_CR32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/bj2700383","volume":"270","author":"MA Soos","year":"1990","unstructured":"Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K: Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J. 1990, 270: 383-390.","journal-title":"Biochem J"},{"key":"98_CR33","doi-asserted-by":"crossref","first-page":"13238","DOI":"10.1016\/S0021-9258(18)51620-3","volume":"264","author":"CP Moxham","year":"1989","unstructured":"Moxham CP, Duronio V, Jacobs S: Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem. 1989, 264: 13238-13244.","journal-title":"J Biol Chem"},{"key":"98_CR34","first-page":"1935","volume":"5","author":"G Pandini","year":"1999","unstructured":"Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, Goldfine ID, Belfiore A: Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin\/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res. 1999, 5: 1935-1944.","journal-title":"Clin Cancer Res"},{"key":"98_CR35","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-11-0022","volume":"47","author":"K Siddle","year":"2011","unstructured":"Siddle K: Signalling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol. 2011, 47: R1-R10.","journal-title":"J Mol Endocrinol"},{"key":"98_CR36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1677\/erc.1.01264","volume":"14","author":"PH Peeters","year":"2007","unstructured":"Peeters PH, Lukanova A, Allen N, Berrino F, Key T, Dossus L, Rinaldi S, van Gils CH, Bueno-de-Mesquita HB, Boeing H, Schulz M, Chang-Claude J, Linseisen J, Panico S, Sacerdote C, Palli D, Tumino R, Trichopoulou A, Trichopolos D, Bamia C, Larranaga N, Ardanaz E, Pera G, Quir\u00f3s JR, Mart\u00ednez-Garc\u00eda C, Navarro C, Bingham SA, Khaw KT, Clavel F, Tjonneland A, Olsen A, Overvad K, Tetsche MS, Lund E, Lundin E, Berglund G, Riboli E, Kaaks R: Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer. 2007, 14: 81-90.","journal-title":"Endocr Relat Cancer"},{"key":"98_CR37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ijc.10613","volume":"101","author":"A Lukanova","year":"2002","unstructured":"Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Zeleniuch-Jacquotte A, Berrino F, Hallmans G, Riboli E, Kaaks R: Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer. 2002, 101: 549-554.","journal-title":"Int J Cancer"},{"key":"98_CR38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/08977190701838402","volume":"25","author":"J Brokaw","year":"2007","unstructured":"Brokaw J, Katsaros D, Wiley A, Lu L, Su D, Sochirca O, de la Longrais IA, Mayne S, Risch H, Yu H: IGF-I in epithelial ovarian cancer and its role in disease progression. Growth Factors. 2007, 25: 346-354.","journal-title":"Growth Factors"},{"key":"98_CR39","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1757-2215-6-12","volume":"6","author":"SM King","year":"2013","unstructured":"King SM, Modi DA, Eddie SL, Burdette JE: Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway. J Ovarian Res. 2013, 6: 12-","journal-title":"J Ovarian Res"},{"key":"98_CR40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2004.10.012","volume":"96","author":"RA Sayer","year":"2005","unstructured":"Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR, Berchuck A: High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecol Oncol. 2005, 96: 355-361.","journal-title":"Gynecol Oncol"},{"key":"98_CR41","first-page":"3825","volume":"23","author":"MR Cardillo","year":"2003","unstructured":"Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F, Toscano V: Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Res. 2003, 23: 3825-3835.","journal-title":"Anticancer Res"},{"key":"98_CR42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00384-004-0675-4","volume":"20","author":"R Durai","year":"2005","unstructured":"Durai R, Yang W, Gupta S, Seifalian AM, Winslet MC: The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis. 2005, 20: 203-220.","journal-title":"Int J Colorectal Dis"},{"key":"98_CR43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.ju.0000071474.70103.92","volume":"170","author":"A Parker","year":"2003","unstructured":"Parker A, Cheville JC, Lohse C, Cerhan JR, Blute ML: Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma. J Urol. 2003, 170: 420-424.","journal-title":"J Urol"},{"key":"98_CR44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.leu.2403997","volume":"20","author":"WJ Chng","year":"2006","unstructured":"Chng WJ, Gualberto A, Fonseca R: IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma. Leukemia. 2006, 20: 174-176.","journal-title":"Leukemia"},{"key":"98_CR45","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0277-5379(88)90332-X","volume":"24","author":"JP Peyrat","year":"1988","unstructured":"Peyrat JP, Bonneterre J, Laurent JC, Louchez MM, Amrani S, Leroy-Martin B, Vilain MO, Delobelle A, Demaille A: Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease. Eur J Cancer Clin Oncol. 1988, 24: 1425-1431.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"98_CR46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1159\/000242253","volume":"32","author":"Y An","year":"2009","unstructured":"An Y, Cai L, Wang Y, Zhu D, Guan Y, Zheng J: Local expression of insulin-like growth factor-I, insulin-like growth factor-I receptor, and estrogen receptor alpha in ovarian cancer. Onkologie. 2009, 32: 638-644.","journal-title":"Onkologie"},{"key":"98_CR47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0959-8049(00)00423-8","volume":"37","author":"D Katsaros","year":"2001","unstructured":"Katsaros D, Yu H, Levesque MA, Danese S, Genta F, Richiardi G, Fracchioli S, Khosravi MJ, Diamandi A, Gordini G, Diamandis EP, Massobrio M: IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival. Eur J Cancer. 2001, 37: 478-485.","journal-title":"Eur J Cancer"},{"key":"98_CR48","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/sj.onc.1210864","volume":"27","author":"PL Torng","year":"2008","unstructured":"Torng PL, Lee YC, Huang CY, Ye JH, Lin YS, Chu YW, Huang SC, Cohen P, Wu CW, Lin CT: Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma. Oncogene. 2008, 27: 2137-2147.","journal-title":"Oncogene"},{"key":"98_CR49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0955-2235(91)90003-M","volume":"3","author":"S Shimasaki","year":"1991","unstructured":"Shimasaki S, Ling N: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, \u22122, \u22123, \u22124, \u22125 and \u22126). Prog Growth Factor Res. 1991, 3: 243-266.","journal-title":"Prog Growth Factor Res"},{"key":"98_CR50","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnci\/djs258","volume":"104","author":"D Yee","year":"2012","unstructured":"Yee D: Insulin-like growth factor receptor inhibitors: baby or the bathwater?. J Natl Cancer Inst. 2012, 104: 975-981.","journal-title":"J Natl Cancer Inst"},{"key":"98_CR51","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1158\/0008-5472.CAN-09-2141","volume":"70","author":"R Novosyadlyy","year":"2010","unstructured":"Novosyadlyy R, Lann DE, Vijayakumar A, Rowzee A, Lazzarino DA, Fierz Y, Carboni JM, Gottardis MM, Pennisi PA, Molinolo AA, Kurshan N, Mejia W, Santopietro S, Yakar S, Wood TL, LeRoith D: Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res. 2010, 70: 741-751.","journal-title":"Cancer Res"},{"key":"98_CR52","doi-asserted-by":"crossref","unstructured":"Evans CRL T, Chan E, Tait B, Michael SA, Day S, Stephens AW, Franke A, Poondru S, Puzanov I: Phase I dose-escalation study of continuous oral dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), in patients with advanced solid tumors.J Clin Oncol 2010, 28:15s. (suppl; abstr 2531).,","DOI":"10.1200\/jco.2010.28.15_suppl.2531"},{"key":"98_CR53","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/JTO.0b013e3181ba2f1d","volume":"4","author":"DD Karp","year":"2009","unstructured":"Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, Gualberto A: Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin. J Thorac Oncol. 2009, 4: 1397-1403.","journal-title":"J Thorac Oncol"},{"key":"98_CR54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1615\/CritRevOncog.v17.i2.30","volume":"17","author":"DN Boone","year":"2012","unstructured":"Boone DN, Lee AV: Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling. Crit Rev Oncog. 2012, 17: 161-173.","journal-title":"Crit Rev Oncog"},{"key":"98_CR55","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1535-7163.MCT-09-0381","volume":"8","author":"J Zha","year":"2009","unstructured":"Zha J, O\u2019Brien C, Savage H, Huw LY, Zhong F, Berry L, Lewis Phillips GD, Luis E, Cavet G, Hu X, Amler LC, Lackner MR: Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer. Mol Cancer Ther. 2009, 8: 2110-2121.","journal-title":"Mol Cancer Ther"},{"key":"98_CR56","first-page":"5073","volume":"63","author":"EK Maloney","year":"2003","unstructured":"Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, Zhou XM, Blattler WA, Chittenden T, Singh R: An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res. 2003, 63: 5073-5083.","journal-title":"Cancer Res"},{"key":"98_CR57","doi-asserted-by":"crossref","first-page":"17235","DOI":"10.1074\/jbc.M110.118620","volume":"285","author":"J Boucher","year":"2010","unstructured":"Boucher J, Tseng YH, Kahn CR: Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription. J Biol Chem. 2010, 285: 17235-17245.","journal-title":"J Biol Chem"},{"key":"98_CR58","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood.V78.4.921.921","volume":"78","author":"JA McCubrey","year":"1991","unstructured":"McCubrey JA, Steelman LS, Mayo MW, Algate PA, Dellow RA, Kaleko M: Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. Blood. 1991, 78: 921-929.","journal-title":"Blood"},{"key":"98_CR59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1677\/JME-09-0021","volume":"43","author":"SI Chisalita","year":"2009","unstructured":"Chisalita SI, Johansson GS, Liefvendahl E, Back K, Arnqvist HJ: Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2. J Mol Endocrinol. 2009, 43: 231-239.","journal-title":"J Mol Endocrinol"},{"key":"98_CR60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0014-4827(54)90176-7","volume":"6","author":"M Abercrombie","year":"1954","unstructured":"Abercrombie M, Heaysman JE: Observations on the social behaviour of cells in tissue culture. II. Monolayering of fibroblasts. Exp Cell Res. 1954, 6: 293-306.","journal-title":"Exp Cell Res"},{"key":"98_CR61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ceb.2012.06.009","volume":"24","author":"AI McClatchey","year":"2012","unstructured":"McClatchey AI, Yap AS: Contact inhibition (of proliferation) redux. Curr Opin Cell Biol. 2012, 24: 685-694.","journal-title":"Curr Opin Cell Biol"},{"key":"98_CR62","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1128\/MCB.01443-08","volume":"29","author":"DC Clarke","year":"2009","unstructured":"Clarke DC, Brown ML, Erickson RA, Shi Y, Liu X: Transforming growth factor beta depletion is the primary determinant of Smad signaling kinetics. Mol Cell Biol. 2009, 29: 2443-2455.","journal-title":"Mol Cell Biol"},{"key":"98_CR63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1478-811X-9-10","volume":"9","author":"LA Walsh","year":"2011","unstructured":"Walsh LA, Damjanovski S: IGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-beta1 resulting in epithelial to mesenchymal transition. Cell Commun Signal. 2011, 9: 10-","journal-title":"Cell Commun Signal"},{"key":"98_CR64","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/ERC-11-0136","volume":"18","author":"CJ Dool","year":"2011","unstructured":"Dool CJ, Mashhedi H, Zakikhani M, David S, Zhao Y, Birman E, Carboni JM, Gottardis M, Blouin MJ, Pollak M: IGF1\/insulin receptor kinase inhibition by BMS-536924 is better tolerated than alloxan-induced hypoinsulinemia and more effective than metformin in the treatment of experimental insulin-responsive breast cancer. Endocr Relat Cancer. 2011, 18: 699-709.","journal-title":"Endocr Relat Cancer"},{"key":"98_CR65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/483531a","volume":"483","author":"CG Begley","year":"2012","unstructured":"Begley CG, Ellis LM: Drug development: Raise standards for preclinical cancer research. Nature. 2012, 483: 531-533.","journal-title":"Nature"},{"key":"98_CR66","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1210\/endo-122-5-2044","volume":"122","author":"RW Furlanetto","year":"1988","unstructured":"Furlanetto RW: Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells. Endocrinology. 1988, 122: 2044-2053.","journal-title":"Endocrinology"},{"key":"98_CR67","first-page":"a017459","volume":"5","author":"LK Goh","year":"2013","unstructured":"Goh LK, Sorkin A: Endocytosis of receptor tyrosine kinases. Cold Spring Harb Perspect Biol. 2013, 5: a017459-","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"98_CR68","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1158\/0008-5472.CAN-07-6364","volume":"68","author":"B Sehat","year":"2008","unstructured":"Sehat B, Andersson S, Girnita L, Larsson O: Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Cancer Res. 2008, 68: 5669-5677.","journal-title":"Cancer Res"},{"key":"98_CR69","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1126\/science.274.5295.2086","volume":"274","author":"AV Vieira","year":"1996","unstructured":"Vieira AV, Lamaze C, Schmid SL: Control of EGF receptor signaling by clathrin-mediated endocytosis. Science. 1996, 274: 2086-2089.","journal-title":"Science"},{"key":"98_CR70","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<512::AID-JCP6>3.0.CO;2-S","volume":"166","author":"CC Reddy","year":"1996","unstructured":"Reddy CC, Wells A, Lauffenburger DA: Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha. J Cell Physiol. 1996, 166: 512-522.","journal-title":"J Cell Physiol"},{"key":"98_CR71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1021\/bp00014a007","volume":"8","author":"C Starbuck","year":"1992","unstructured":"Starbuck C, Lauffenburger DA: Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses. Biotechnol Prog. 1992, 8: 132-143.","journal-title":"Biotechnol Prog"},{"key":"98_CR72","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1016\/S0021-9258(18)91060-4","volume":"259","author":"DJ Knauer","year":"1984","unstructured":"Knauer DJ, Wiley HS, Cunningham DD: Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system. J Biol Chem. 1984, 259: 5623-5631.","journal-title":"J Biol Chem"},{"key":"98_CR73","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1210\/endo.134.1.7506211","volume":"134","author":"S Kanzaki","year":"1994","unstructured":"Kanzaki S, Hilliker S, Baylink DJ, Mohan S: Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and \u22125 proteases. Endocrinology. 1994, 134: 383-392.","journal-title":"Endocrinology"},{"key":"98_CR74","first-page":"131","volume":"3","author":"M Ohtani","year":"2009","unstructured":"Ohtani M, Numazaki M, Yajima Y, Fujita-Yamaguchi Y: Mechanisms of antibody-mediated insulin-like growth factor I receptor (IGF-IR) down-regulation in MCF-7 breast cancer cells. Biosci Trends. 2009, 3: 131-138.","journal-title":"Biosci Trends"},{"key":"98_CR75","doi-asserted-by":"crossref","first-page":"13252","DOI":"10.1073\/pnas.0913476107","volume":"107","author":"JB Spangler","year":"2010","unstructured":"Spangler JB, Neil JR, Abramovitch S, Yarden Y, White FM, Lauffenburger DA, Wittrup KD: Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling. Proc Natl Acad Sci U S A. 2010, 107: 13252-13257.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"98_CR76","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","volume":"30","author":"A Belfiore","year":"2009","unstructured":"Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R: Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009, 30: 586-623.","journal-title":"Endocr Rev"},{"key":"98_CR77","doi-asserted-by":"crossref","first-page":"e55135","DOI":"10.1371\/journal.pone.0055135","volume":"8","author":"FJ Calzone","year":"2013","unstructured":"Calzone FJ, Cajulis E, Chung YA, Tsai MM, Mitchell P, Lu J, Chen C, Sun J, Radinsky R, Kendall R, Beltran PJ: Epitope-specific mechanisms of IGF1R inhibition by ganitumab. PLoS One. 2013, 8: e55135-","journal-title":"PLoS One"},{"key":"98_CR78","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/1535-7163.MCT-08-1171","volume":"8","author":"PJ Beltran","year":"2009","unstructured":"Beltran PJ, Mitchell P, Chung YA, Cajulis E, Lu J, Belmontes B, Ho J, Tsai MM, Zhu M, Vonderfecht S, Baserga R, Kendall R, Radinsky R, Calzone FJ: AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells. Mol Cancer Ther. 2009, 8: 1095-1105.","journal-title":"Mol Cancer Ther"},{"key":"98_CR79","doi-asserted-by":"crossref","first-page":"30169","DOI":"10.1074\/jbc.274.42.30169","volume":"274","author":"BN Kholodenko","year":"1999","unstructured":"Kholodenko BN, Demin OV, Moehren G, Hoek JB: Quantification of short term signaling by the epidermal growth factor receptor. J Biol Chem. 1999, 274: 30169-30181.","journal-title":"J Biol Chem"},{"key":"98_CR80","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nbt0402-370","volume":"20","author":"B Schoeberl","year":"2002","unstructured":"Schoeberl B, Eichler-Jonsson C, Gilles ED, Muller G: Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat Biotechnol. 2002, 20: 370-375.","journal-title":"Nat Biotechnol"},{"key":"98_CR81","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/msb4100188","volume":"3","author":"MR Birtwistle","year":"2007","unstructured":"Birtwistle MR, Hatakeyama M, Yumoto N, Ogunnaike BA, Hoek JB, Kholodenko BN: Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses. Mol Syst Biol. 2007, 3: 144-","journal-title":"Mol Syst Biol"},{"key":"98_CR82","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/msb.2008.74","volume":"5","author":"WW Chen","year":"2009","unstructured":"Chen WW, Schoeberl B, Jasper PJ, Niepel M, Nielsen UB, Lauffenburger DA, Sorger PK: Input\u2013output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data. Mol Syst Biol. 2009, 5: 239-","journal-title":"Mol Syst Biol"},{"key":"98_CR83","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-10-0460","volume":"70","author":"S Iadevaia","year":"2010","unstructured":"Iadevaia S, Lu Y, Morales FC, Mills GB, Ram PT: Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. Cancer Res. 2010, 70: 6704-6714.","journal-title":"Cancer Res"},{"key":"98_CR84","doi-asserted-by":"crossref","first-page":"e66870","DOI":"10.1371\/journal.pone.0066870","volume":"8","author":"L Zhang","year":"2013","unstructured":"Zhang L, Smith DW, Gardiner BS, Grodzinsky AJ: Modeling the insulin-like growth factor system in articular cartilage. PLoS One. 2013, 8: e66870-","journal-title":"PLoS One"},{"key":"98_CR85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/bit.23297","volume":"109","author":"RD Prasasya","year":"2012","unstructured":"Prasasya RD, Vang KZ, Kreeger PK: A multivariate model of ErbB network composition predicts ovarian cancer cell response to canertinib. Biotechnol Bioeng. 2012, 109: 213-224.","journal-title":"Biotechnol Bioeng"},{"key":"98_CR86","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrm1050","volume":"4","author":"P Ghosh","year":"2003","unstructured":"Ghosh P, Dahms NM, Kornfeld S: Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol. 2003, 4: 202-212.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"98_CR87","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1016\/S0021-9258(17)37642-1","volume":"269","author":"SU Shin","year":"1994","unstructured":"Shin SU, Friden P, Moran M, Morrison SL: Functional properties of antibody insulin-like growth factor fusion proteins. J Biol Chem. 1994, 269: 4979-4985.","journal-title":"J Biol Chem"},{"key":"98_CR88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0955-2235(95)00022-4","volume":"6","author":"GJ Pommier","year":"1995","unstructured":"Pommier GJ, Remacle-Bonnet MM, Tripier SG, Garrouste FL: Differential secretory polarity of IGFBP-6 vs. IGFBP-2 and IGFBP-4 in human intestinal epithelial cells: is it a way of modulating IGF-II bioavailability towards the IGF-responsive basolateral surface?. Prog Growth Factor Res. 1995, 6: 197-206.","journal-title":"Prog Growth Factor Res"},{"key":"98_CR89","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1515\/JPEM.1999.12.4.475","volume":"12","author":"D Accili","year":"1999","unstructured":"Accili D, Nakae J, Kim JJ, Park BC, Rother KI: Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development. J Pediatr Endocrinol Metab. 1999, 12: 475-485.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"98_CR90","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1600-0854.2007.00655.x","volume":"8","author":"A Jurgeit","year":"2007","unstructured":"Jurgeit A, Berlato C, Obrist P, Ploner C, Massoner P, Schmolzer J, Haffner MC, Klocker H, Huber LA, Geley S, Doppler W: Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus. Traffic. 2007, 8: 1815-1828.","journal-title":"Traffic"},{"key":"98_CR91","doi-asserted-by":"crossref","first-page":"11533","DOI":"10.1021\/bi049082k","volume":"43","author":"SA Robinson","year":"2004","unstructured":"Robinson SA, Rosenzweig SA: Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1\/IGFBP-2 AND IGFBP-3 interface. Biochemistry. 2004, 43: 11533-11545.","journal-title":"Biochemistry"},{"key":"98_CR92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(90)90958-E","volume":"518","author":"A Danielsen","year":"1990","unstructured":"Danielsen A, Larsen E, Gammeltoft S: Chromaffin cells express two types of insulin-like growth factor receptors. Brain Res. 1990, 518: 95-100.","journal-title":"Brain Res"},{"issue":"Pt 2","key":"98_CR93","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/bj2810413","volume":"281","author":"EL Germain-Lee","year":"1992","unstructured":"Germain-Lee EL, Janicot M, Lammers R, Ullrich A, Casella SJ: Expression of a type I insulin-like growth factor receptor with low affinity for insulin-like growth factor II. Biochem J. 1992, 281 (Pt 2): 413-417.","journal-title":"Biochem J"},{"key":"98_CR94","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/j.1460-2075.1989.tb03517.x","volume":"8","author":"R Lammers","year":"1989","unstructured":"Lammers R, Gray A, Schlessinger J, Ullrich A: Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains. EMBO J. 1989, 8: 1369-1375.","journal-title":"EMBO J"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12918-014-0098-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-014-0098-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12918-014-0098-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T06:01:36Z","timestamp":1649916096000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/s12918-014-0098-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,13]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1186\/s12918-014-0098-y","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,13]]},"article-number":"98"}}